KLK3 and posterior cortical atrophy: Despite the recent controversy and discovery of additional novel biomarkers for PCa, prostate specific antigen (PSA) remains the most widely used tool for PCa screening and plays a key role in decreasing mortality from the disease ( 1 , 3 ).